It is also found that genetic alteration or gene amplification of metastasis gene metadherin (MTDH) is associated with more than 40% breast cancer cases with poor clinical outcomes.93 These findings establish that anticancer drugs targeting ABC transporters and MTDH can be used in increasing the chemotherapeutic efficacy and reducing metastasis risk. Here, MTDH is linked to breast cancer.